Wang Guang-Yun, Wang Tie-Zheng, Zhang Yuan-Yuan, Li Fang, Yu Bo-Yang, Kou Jun-Ping
State Key Laboratory of Natural Products, Jiangsu Key Laboratory of TCM Evaluation and Translational Research, Department of Pharmacology of Chinese Material Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, People's Republic of China.
State Key Laboratory of Natural Products, Jiangsu Key Laboratory of TCM Evaluation and Translational Research, Department of Resource and Development of Chinese Material Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, People's Republic of China.
Drug Des Devel Ther. 2020 Jan 6;14:13-25. doi: 10.2147/DDDT.S230882. eCollection 2020.
Our previous studies have indicated that non-muscle myosin heavy chain IIA (NMMHC IIA) is involved in HO-induced neuronal apoptosis, which is associated with the positive feedback loop of caspase-3/ROCK1/MLC pathway. However, the neuroprotective effect of NMMHC IIA inhibition with an adeno-associated virus (AAV) vector after transient middle cerebral artery occlusion (MCAO) and its role in caspases-3/ROCK1/MLC pathway remain blurred.
Green fluorescent protein (GFP) and a small hairpin RNA targeting Myh9 (encoding NMMHC IIA) were cloned and packaged into the AAV9 vector. AAV-shMyh9 or control vector were injected into C57BL/6J mice four weeks prior to 60 min MCAO. Twenty-four hours after reperfusion, functional and histological analyses of the mice were performed.
In this study, AAV-shMyh9 was used to down-regulate NMMHC IIA expression in mice. We found that down-regulation of NMMHC IIA could improve neurological scores and histological injury in ischemic mice. Ischemic attack also activated neuronal apoptosis, and this effect was partially attenuated when NMMHC IIA was inhibited by AAV-shMyh9. In addition, AAV-shMyh9 significantly reduced cerebral ischemic/reperfusion (I/R)-induced NMMHC IIA-actin interaction, caspase-3 cleavage, Rho-associated kinase1 (ROCK1) activation and myosin light-chains (MLC) phosphorylation.
Consequently, we showed that AAV-shMyh9 inhibits I/R-induced neuronal apoptosis linked with caspase-3/ROCK1/MLC/NMMHC IIA-actin cascade, which has also been confirmed to be a positive feedback loop. These findings put some insights into the neuroprotective effect of AAV-shMyh9 associated with the regulation of NMMHC IIA-related pathway under ischemic attack and provide a therapeutic strategy for ischemic stroke.
我们之前的研究表明,非肌肉肌球蛋白重链IIA(NMMHC IIA)参与了缺氧诱导的神经元凋亡,这与半胱天冬酶-3/ROCK1/肌球蛋白轻链(MLC)通路的正反馈回路有关。然而,在短暂性大脑中动脉闭塞(MCAO)后,腺相关病毒(AAV)载体抑制NMMHC IIA的神经保护作用及其在半胱天冬酶-3/ROCK1/MLC通路中的作用仍不明确。
将绿色荧光蛋白(GFP)和靶向Myh9(编码NMMHC IIA)的小发夹RNA克隆并包装到AAV9载体中。在MCAO 60分钟前四周,将AAV-shMyh9或对照载体注射到C57BL/6J小鼠体内。再灌注24小时后,对小鼠进行功能和组织学分析。
在本研究中,使用AAV-shMyh9下调小鼠体内NMMHC IIA的表达。我们发现,下调NMMHC IIA可改善缺血小鼠的神经功能评分和组织学损伤。缺血攻击还激活了神经元凋亡,而当AAV-shMyh9抑制NMMHC IIA时,这种作用部分减弱。此外,AAV-shMyh9显著降低了脑缺血/再灌注(I/R)诱导的NMMHC IIA-肌动蛋白相互作用、半胱天冬酶-3裂解、Rho相关激酶1(ROCK1)激活和肌球蛋白轻链(MLC)磷酸化。
因此,我们表明AAV-shMyh9抑制了与半胱天冬酶-3/ROCK1/MLC/NMMHC IIA-肌动蛋白级联反应相关的I/R诱导的神经元凋亡,这也被证实是一个正反馈回路。这些发现为缺血攻击下AAV-shMyh9与NMMHC IIA相关通路调节相关的神经保护作用提供了一些见解,并为缺血性中风提供了一种治疗策略。